Journals / Turkish Journal of Gastroenterology / 2012 / Cilt: 23 - Sayı: 3

Fasioliasis: Üç farklı klinikle başvuran üç olgu

Fascioliasis: 3 cases with three different clinical presentations

Pages
267–271
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report the clinical and laboratory assessment and therapeutic approach of a series of three cases diagnosed (in order of) one week, three months and one and a half years after presentation of the first symptoms of the disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fascioliasis, which is a zoonotic infestation caused by the trematode Fasciola hepatica (liver fluke), is primarily a disease of herbivorous animals such as sheep and cattle.
📊
Key Findings & Data:As a result of newly introduced serological assays facilitating the diagnosis, there has been an increase in the number of reported cases.
💡
Conclusion & Impact:Here, we report the clinical and laboratory assessment and therapeutic approach of a series of three cases diagnosed (in order of) one week, three months and one and a half years after presentation of the first symptoms of the disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Orta yaşlı · Kadın · Erişkin

Abstract

Fascioliasis, which is a zoonotic infestation caused by the trematode Fasciola hepatica (liver fluke), is primarily a disease of herbivorous animals such as sheep and cattle. Humans become accidental hosts through ingesting uncooked aquatic plants such as watercress. It presents a wide spectrum of clinical pictures ranging from fever, eosinophilia and vague gastrointestinal symptoms in the acute phase to cholangitis, cholecystitis, biliary obstruction, extrahepatic infestation, or asymptomatic eosinophilia in the chronic phase. However, it may often be overlooked, especially in the acute phase, because of vague symptoms. As a result of newly introduced serological assays facilitating the diagnosis, there has been an increase in the number of reported cases. Here, we report the clinical and laboratory assessment and therapeutic approach of a series of three cases diagnosed (in order of) one week, three months and one and a half years after presentation of the first symptoms of the disease.

Özet

Fasciola hepatica (karaciğer şeriti) adlı trematodun etken olduğu zoonotik bir infestasyon olan fasiyoliazis, primer olarak koyun ve sığır gibi otçul hayvanların hastalığıdır. ‹nsanlar, su teresi gibi su bitkilerinin çiğ yenmesiyle konak olurlar. Akut fazda ateş, eozinofili ve silik gastrointestinal semptomlardan kronik fazda kolanjit, kolesistit, safrayolu tıkanıklığı, karaciğerdışı infestasyon veya asemptomatik eozinofili gibi geniş bir yelpazede klinik tablolara neden olabilir. Bununla beraber, özellikle akut fazda silik semptomlar nedeniyle çoğunlukla atlanabilmektedir. Tanıyı kolaylaştıran yeni serolojik testlerin kullanılmasıyla, bildirilen olgu sayı- sında artış olmuştur. Burada, semptomların başlangıcından sonra sırasıyla bir hafta, üç ay ve bir buçuk yıl sonra tanı koyduğumuz üç olgunun klinik, laboratuvar değerlendirmesi ve tedavi yaklaşımını bildirmekteyiz.

🔖

Cite This Article

ARSLAN, F., BATIREL, A., SAMASTI, M., TABAK, F., MERT, A., ÖZER, S. (2012). Fasioliasis: Üç farklı klinikle başvuran üç olgu. Turkish Journal of Gastroenterology, Cilt: 23 - Sayı: 3, 267–271. https://ajindex.com/articles/411456

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Mas-Coma S. Epidemiology of fascioliasis in human endemic areas. J Helminthol 2005; 79: 207-16
  2. Unat EK, Yücel A, Atlaş K, Samastı M. Fasciola hepatica ve parazitliği. Unat’ın Tıp Parazitolojisi. 4. baskı. ‹stanbul: Universitesi Cerrahpaşa Tıp Fakültesi Yayınları, 1991; 379-86
  3. Esteban JG, Bargues MD, Mas-Coma S. Geographical distribution, diagnosis and treatment of human fascioliasis: a review. Res Rev Parasitol 1998; 58: 13-42
  4. Mas-Coma MS, Esteban JG, Bargues MD. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 1999; 77: 340-6
  5. Harinasuta T, Pungpak S, Keystone JS. Trematode infections. Opisthorchiasis, clonorchiasis, fascioliasis, and paragonimiasis. Infect Dis Clin North Am 1993; 7(3): 699-716
  6. Elkins MRH. Lung and liver flukes. In: Cox REG, Wakelin D, Gillespie SH, Despomier DD, eds. Topley and Wilson's microbiology and microbial infections. Washington DC: Edward Arnold Ltd., 2005
  7. Bahçecioğlu ‹H, Yalmız M, Ataseven H, et al. Biliyer fascioliasis. ERCP ile tanı konulan üç olgu raporu. Türkiye Parazitol Derg 2008; 32: 375-8
  8. Richter J, Knipper M, Göbels K, Haussinger D. Fascioliasis. Current Treatment Options in Infectious Diseases 2002; 4: 313-7
  9. Arjona R, Riancho JA, Aguado JM, et al. Fascioliasis in developed countries: a review of classic and aberrant forms of the disease. Medicine [Baltimore] 1995; 74: 13-23
  10. Marcos LA, Terashima A, Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 2008; 21: 523-30
  11. Xuan le T, Hung NT, Waikagul J. Cutaneous fascioliasis: a case report in Vietnam. Am J Trop Med Hyg 2005; 72: 508- 9
  12. Aksoy DY, Kerimoğlu U, Oto A, et al. Fasciola hepatica infection: clinical and computerized tomographic findings of ten patients. Turk J Gastroenterol 2006; 17: 40-5
  13. Van Beers B, Pringot J, Geubel A, et al. Hepatobiliary fascioliasis: noninvasive imaging findings. Radiology 1990; 174: 809-10
  14. Lopez VR, Dominguez CA, Garron C. Successful treatment of human fascioliasis with tricalbendazole. Eur J Clin Microbiol Infect Dis 1999; 18: 525-6
  15. Marcos LA, Tagle M, Terashima A, et al. Natural history, clinicoradiologic correlates, and response to triclabendazole in acute massive fascioliasis. Am J Trop Med Hyg 2008; 78: 222-7.